VERA
Vera Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +16.7% ·
Aktienfluss -1.9% ·
neue Nettopositionen +14.3%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -2 | 39.21M | $1.68B | +6 | −8 |
| Q1 2026 | 88 | +8 | 35.14M | $1.43B | +11 | −3 |
| Q4 2025 | 79 | +2 | 37.37M | $1.89B | +2 | — |
| Q3 2025 | 14 | -1 | 22.48M | $653.29M | +1 | −3 |
| Q2 2025 | 13 | 0 | 19.02M | $448.09M | +1 | −1 |
| Q1 2025 | 10 | -4 | 8.70M | $208.98M | — | −4 |
| Q4 2024 | 14 | +2 | 9.43M | $398.65M | +2 | — |
| Q3 2024 | 11 | -1 | 7.58M | $334.97M | — | −1 |
| Q2 2024 | 12 | — | 7.20M | $260.63M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.38M | +11.1% | $185.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.38M | +11.1% | $185.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 2.03M | — | $85.69M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 1.15M | +14.8% | $48.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.15M | +14.8% | $48.79M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 837.15K | +43.4% | $35.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 837.15K | +43.4% | $35.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Marshall Wace ✦ | 837.15K | +43.4% | $35.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 480.00K | -65.1% | $20.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 194.03K | +13.1% | $8.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 77.65K | -73.8% | $3.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 74.48K | -42.9% | $3.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 54.81K | +1685.2% | $2.32M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Norges Bank ✦ (passiv) | 48.59K | Neu | $2.05M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 41.45K | -14.6% | $1.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 35.70K | Neu | $1.51M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 18.02K | -10.2% | $761,981 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 18.02K | -10.2% | $761,981 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 18.02K | -10.2% | $761,981 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 18.02K | -10.2% | $761,981 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 7.74K | +15.8% | $327,155 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 7.74K | +15.8% | $327,155 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 7.74K | +15.8% | $327,155 | 0.0% | ▲ Add | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Norges Bank | $2.05M | 0.0% |
| Renaissance Technologies | $1.51M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 229 Inhaber, 72.17M Anteile, $2.73B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.